These data suggest that modulating the expression of SNHG10 and miR-1277-5p could potentially ameliorate the neuroinflammatory condition in Parkinson’s disease, which requires future validation in animal model of Parkinson’s disease. Here, SNHG10 is linked to Parkinson disease.